Cosela
Trilaciclib · G1 Therapeutics, Inc.
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Cosela ingredients
| Active ingredient | Strength |
|---|---|
| Trilaciclib Dihydrochloride | 300 mg/20mL |
What Cosela is used for
Cosela is a cancer medicine (kinase inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Cosela
- Generic name
- Trilaciclib
- Made by
- G1 Therapeutics, Inc.
- Forms
- Injection, Powder, Lyophilized, For Solution
- Given
- Intravenous
- Drug class
- Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA214200
- On the US market since
- 2021
Official information
- Cosela prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Trilaciclib)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Cosela?
Cosela (Trilaciclib) is a cancer medicine made by G1 Therapeutics, Inc., approved by the US FDA.
What are the ingredients of Cosela?
Cosela contains Trilaciclib Dihydrochloride (300 mg/20mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA